期刊文献+

乳腺癌患者手术后局部复发的临床分析

Clinical analysis of local recurrence of breast cancer after operation
原文传递
导出
摘要 目的探讨乳腺癌患者手术后局部复发的影响因素。方法回顾性分析2000年至2008年诊治的671例患者的临床病理资料,行Cox回归模型分析预后影响因素。结果手术后局部复发率为10.7%,Cox回归模型多因素分析显示,淋巴结状态、肿瘤分期、激素受体状态、术后规范化辅助治疗是影响手术后局部复发的重要因素,其中手术后规范化辅助治疗是其保护性因素。结论淋巴结状态、肿瘤分期、激素受体状态、术后规范化辅助治疗对患者的预后评估有重要意义,术后行规范化辅助治疗可降低局部复发。 Objective To explore the influence factors of local recurrence after resection of breast cancer. Methods A retrospective clinical and pathological data of patients hospitalized from 2000 to 2008 were reviewed. Prognostic factors were analyzed by Cox regression model. Results The postoperative local recurrence rate reached 10. 7%. Multivariate Cox regression model analysis showed that tumor stage,lymph node status, hormone receptor status, postoperative standardized treatment are important factors influencing postoperative local recurrence, and the standardized treatment was the protective factor. Conclusions Lymph node status, hormone receptor status ,tumor stage, postoperative adjuvant treatment are important for patient prognosis, and regular postoperative auxiliary treatments help reduce rate of postoperative local recurrence.
作者 丁莹 章阳
出处 《中国肿瘤临床与康复》 2013年第11期1246-1247,共2页 Chinese Journal of Clinical Oncology and Rehabilitation
关键词 乳腺肿瘤 局部复发 临床分析 Breast neoplasms Local recurrence Clinical analysis
  • 相关文献

参考文献8

二级参考文献42

  • 1张斌,蔡玉娥,王仁华,张齐,英子伟,蒋书玲,吴威,王俊时,傅立人.乳腺癌功能性根治术与Halsted标准根治术的比较(附137例分析)[J].实用外科杂志,1989,9(2):77-78. 被引量:2
  • 2管海涛,薛兴欢,王西京,李昂,秦兆寅.靶向survivin的siRNA抑制乳腺癌MCF-7细胞增殖并诱导其凋亡[J].中华肿瘤杂志,2006,28(5):326-330. 被引量:22
  • 3张淑华,葛银林,罗达亚,田润华.小干扰RNA靶向VEGF基因体内外抑制乳腺癌细胞MCF-7的增殖[J].中国生物化学与分子生物学报,2007,23(1):68-73. 被引量:12
  • 4[1]Kenney N J,Saeki T,Gottardis M,et al.Expression of transforming growth factor,an antisense mRNA,inhibits the estrogen-induced production of TGF2 and estrogen-induced proliferation of estrogen-responsive human breast cancer cells.J Cell Physiol,1993,156:497-514.
  • 5[2]Osta W A,Chen Y,Mikhitarian K,et al.EpCAM is over expressed in breast cancer and is a potential target for breast cancer gene therapy.Cancer Res,2004,64:5818-5824.
  • 6[3]Brummelkamp T R,Bernards R,Agami R.A system for stable expression of short interfering RNAs in mammalian cells.Science,2002,296:550-553.
  • 7[4]Leirdal M,Sioud M.Gene silencing in mammalian cells by preformed small RNA duplexes.Biochem Biophys Res Commun,2002,295:744-748.
  • 8[5]Senmaru N,Shichinohe T,TakeuchiM,et al.Supp ression of Erk activation and in vivo growth in esophageal cancer cells by the dominant negative Rasmutant,N116Y.Int J Cancer,1998,78:366-371.
  • 9[6]Lee E J,Jakacka M,Duan W R,et al.Adenovirus-directed expression of dominant negative estrogen receptor induces apoptosis in breast cancer cells and regression of tumors in nude mice.Mol Med,2001,7:773-782.
  • 10[7]Deshane J,Siegal G P,Alvarez R D,et al.Targeted tumor killing via an intracellular antibody against erbB-2.J Clin Invest,1995,96:2980-2989.

共引文献65

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部